Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.
Ellingson BM, Wen PY, Cloughesy TF. · 2017
Read Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. by Ellingson BM, Wen PY, Cloughesy TF. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5398984.txt.
Description
Benjamin M. Ellingson, Patrick Y. Wen, and Timothy F. Cloughesy propose updated scan rules for glioblastoma trials in a 2017 paper in Neurotherapeutics. Glioblastoma is a fast, deadly brain tumor. Trials judge new drugs in part by whether scans show the tumor shrinking or growing. The standing rules, called RANO, fixed many flaws of older guides, but hard cases remain, such as swelling that mimics growth after radiation.
The authors suggest measuring tumor volume rather than flat size, and using special scan maps that make tumors stand out. They drop the need to grade non-bright tumor parts by eye. They set the scan after radiation as the start point for new cases. Their rules also sort true growth from fake growth or fake shrinkage in both new and returned disease.
Catalog record
| CREATOR | Ellingson BM, Wen PY, Cloughesy TF. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |